Posted by Clinical Lab Products | Jan 3, 2004 | Cancer, Miscellaneous |
By Renee DiIulio Continuous screening can help detect recurrent bladder cancer early and thereby increase a patient’s longevity. Yet, according to research published earlier this year, many patients are not getting the recommended follow-up
Read MorePosted by Clinical Lab Products | Jan 1, 2004 | Compliance, Lab Management |
Regulatory Climate Marked by New CLIA Rules and Concerns About Protecting Laboratory Workers
Read MorePosted by Clinical Lab Products | Dec 12, 2003 | Miscellaneous |
Better Collaboration Between the Emergency Department and the Clinical Lab Can Improve Clinical Outcomes for Patients With ACS By Djiby Diop, MD, MMS, MPH Given the current health care system, there is no doubt that the emergency department (ED)
Read MorePosted by Clinical Lab Products | Dec 11, 2003 | Miscellaneous, Osteoporosis |
AusAm Biotechnologies Receives Approval to Market Test for Kidney Disease AusAm Biotechnologies Inc has received the CE Mark of approval for the Microalbumin Plus™, which aids in the detection of microalbuminari
Read MorePosted by Clinical Lab Products | Dec 6, 2003 | Cancer, Miscellaneous, Osteoporosis |
ImmuKnow™: A Pharmacodynamic Assay for Managing Immunosuppressive Drug Therapy
Read More